RankAlpha logo
Back to Rankings

FBIO

Fortress BiotechA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-17
View Chart
Current thesis
The constructive case is that Fortress has already converted portfolio assets into tangible value through ZYCUBO approval, PRV monetization, debt reduction, and a new royalty stream from UNLOXCYT, while management also pointed to future ZYCUBO royalties, possible milestone payments, and anselamimab optionality [#SEC-8K-2026-05-14].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Fortress remains dependent on partner execution and external regulatory timelines, including anselamimab and other partnered assets, which can slip without much warning [#SEC-8K-2026-05-14].
Momentum
83
Value
70
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.40 · Bull $5.20 · Bear $2.10
Data freshness
Prices
As of 2026-07-17
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-17 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-11 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-17
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $5.00
Why
Momentum83 · Δ7d +19.5
Value70 · Δ7d -0.2
Sentiment61 · Δ7d -13.1
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
83
26% active weight
Current posture
7d trendImproving
Δ7d
+19.5
Δ21d
+13.7
Value
70
39% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
+0.0
Sentiment
61
34% active weight
Current posture
7d trendSoftening
Δ7d
-13.1
Δ21d
+58.2
Why this grade

Composite grade A. Momentum 82.5 / Value 69.9 / Sentiment 61.1

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$111.62M
Beta
1.44
Shares Out
33.22M
P/E (TTM) · Derived
-49.9
P/S (TTM)
2.13
P/FCF (TTM) · Derived
0.93
Rev YoY
+22.1%
EPS YoY
-686.9%
Gross Margin
+59.1%
Op Margin
-100.0%
Net Debt
-$12.17M
Current Ratio
2.86
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology